Data from the SAPPHIRE study formed the basis of Scholar Rock's U.S. Food and Drug Administration request to approve apitegromab for SMA.

Seattle City Council President Sara Nelson joined SMN live in the studio to discuss the new bill approved by the council to ...

Scholar Rock will present new Phase 3 SAPPHIRE trial data on apitegromab at the 2025 MDA conference, highlighting efficacy ...

CRANBROOK, BC / ACCESS Newswire / March 17, 2025 / Eagle Plains Resources Ltd. (TSX-V:EPL) ("EPL" or "Eagle Plains") and Sun ...

A child with a rare genetic disorder — spinal muscular atrophy type I — was treated prenatally for the first time. Courtesy of Jakob Owens  via Unsplash During an amniocentesis test, a long, thin ...

Scholar Rock (SRRK) announced that new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial will be presented in multiple clinical ...

A multidisciplinary approach, early diagnosis, and comprehensive caregiver education are crucial in effectively managing ...

The spring months (March-May) are typically the hottest in Mexico City, with temperatures cooling off once the rainy season ...

In response to a letter from David Lawson, MD, (SMN, Feb. 26 issue) I would like to point out that even a simple Google ...

To address these issues, we propose SMN-YOLO, a lightweight small object detector based on YOLOv8n. Our approach introduces spatial-channel decoupling downsampling to reduce model size while retaining ...

Sharks rookie centers Macklin Celebrini and Will Smith faced a tough task adapting to the brutal demands of the NHL, a challenge which San Jose assistant general manager Ryan Clowe believes the ...